98 related articles for article (PubMed ID: 25515240)
1. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells.
Allen WL; Turkington RC; Stevenson L; Carson G; Coyle VM; Hector S; Dunne P; Van Schaeybroeck S; Longley DB; Johnston PG
Mol Cancer Ther; 2012 Aug; 11(8):1724-34. PubMed ID: 22665525
[TBL] [Abstract][Full Text] [Related]
3. A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer.
Allen WL; Stevenson L; Coyle VM; Jithesh PV; Proutski I; Carson G; Gordon MA; Lenz HJ; Van Schaeybroeck S; Longley DB; Johnston PG
Mol Cancer Ther; 2012 Jan; 11(1):119-31. PubMed ID: 22027693
[TBL] [Abstract][Full Text] [Related]
4. Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy.
Litvak DA; Bilchik AJ; Cabot MC
J Gastrointest Surg; 2003 Jan; 7(1):140-148. PubMed ID: 12559195
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy.
Papaevangelou E; Almeida GS; Jamin Y; Robinson SP; deSouza NM
Br J Cancer; 2015 Apr; 112(9):1471-9. PubMed ID: 25880014
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan therapy and molecular targets in colorectal cancer: a systemic review.
Weekes J; Lam AK; Sebesan S; Ho YH
World J Gastroenterol; 2009 Aug; 15(29):3597-602. PubMed ID: 19653336
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis.
Matrka MC; Watanabe M; Muraleedharan R; Lambert PF; Lane AN; Romick-Rosendale LE; Wells SI
PLoS One; 2017; 12(5):e0177952. PubMed ID: 28558019
[TBL] [Abstract][Full Text] [Related]
8. Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 Breast Cancer Cells.
Wen Y; Xu HN; Privette Vinnedge L; Feng M; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):410-416. PubMed ID: 30758703
[TBL] [Abstract][Full Text] [Related]
9. Super-resolution microscopy reveals the nanoscale cluster architecture of the DEK protein cancer biomarker.
Pierzynska-Mach A; Diaspro A; Cella Zanacchi F
iScience; 2023 Nov; 26(11):108277. PubMed ID: 38026229
[TBL] [Abstract][Full Text] [Related]
10. RESPONSE: Emergence of a New Optical Marker for Colorectal Neoplasms: To What Extent Should We Accept It?
Hisabe T
Clin Endosc; 2022 Mar; 55(2):315-317. PubMed ID: 35391521
[No Abstract] [Full Text] [Related]
11. Emergence of a New Optical Marker for Colorectal Neoplasms: To What Extent Should We Accept It?
Lee HH
Clin Endosc; 2022 Mar; 55(2):315-317. PubMed ID: 35184526
[No Abstract] [Full Text] [Related]
12. The DEK oncoprotein and its emerging roles in gene regulation.
Sandén C; Gullberg U
Leukemia; 2015 Aug; 29(8):1632-6. PubMed ID: 25765544
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues.
De Felice F; Musio D; Izzo L; Tombolini V
World J Gastrointest Oncol; 2014 Dec; 6(12):438-40. PubMed ID: 25516776
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells.
Tian X; Zhu Z; Wang G; Xu J; Liang A; Zhang W
Dis Markers; 2022; 2022():9312971. PubMed ID: 35769815
[TBL] [Abstract][Full Text] [Related]
15. Potential of
Habiburrahman M; Wardoyo MP; Sutopo S; Rahadiani N
Mol Clin Oncol; 2022 Jul; 17(1):117. PubMed ID: 35747597
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Proteins with Inverted Repeats and Cruciform Structures in Nucleic Acids.
Bowater RP; Bohálová N; Brázda V
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682854
[TBL] [Abstract][Full Text] [Related]
17. DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma.
Yi H; Duan H; Shi W; Liu Z; Liu Y
Arch Med Sci; 2021; 17(1):135-141. PubMed ID: 33488866
[TBL] [Abstract][Full Text] [Related]
18. CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
Wang J; Wen T; Li Z; Che X; Gong L; Jiao Z; Qu X; Liu Y
Aging (Albany NY); 2020 Nov; 13(2):1883-1897. PubMed ID: 33232276
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer.
Ye SB; Cheng YK; Hu JC; Gao F; Lan P
Ann Transl Med; 2020 Feb; 8(4):96. PubMed ID: 32175389
[TBL] [Abstract][Full Text] [Related]
20. UNR/
Martinez-Useros J; Garcia-Carbonero N; Li W; Fernandez-Aceñero MJ; Cristobal I; Rincon R; Rodriguez-Remirez M; Borrero-Palacios A; Garcia-Foncillas J
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31027221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
